Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies

Fig. 3

Kaplan-Meier curves for survival without events during 1-year of follow-up, in patients receiving zofenopril with xanthine oxidase inhibitors or XOIs (+) as respect to those treated with zofenopril without (−) XOIs, those treated with placebo or other angiotensin converting enzyme (ACE)-inhibitors plus XOIs, those treated with placebo or other ACE-inhibitors without concomitant XOIs. P-values for the between-group comparison based on Log Rank Test are reported in each panel

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us